FreeStyle Libre 2 System

WITH UNSURPASSED 14-DAY ACCURACY1 AND OPTIONAL, REAL-TIME GLUCOSE ALARMS* THAT ARE EASY FOR YOU AND YOUR PATIENTS†2

The #1 CGM in the US

Freestyle Libre 2 System
Freestyle Libre 2 System

Optional, real-time glucose alarms* let your patients know when their glucose is too high or low

No fingersticks§ required even when glucose is low, falling, or rapidly changing1

Small, discreet sensor that's easy for patients†2

Painless2 glucose readings with a simple scan allows patients to see their glucose reading, trend arrow, and
8-hour history

Easy-to-understand reports help patients make better treatment decisions†§‡2

Real-time Alarms* Without Scanning

FreeStyle Libre 2 system, now with simple, easy-to-use real-time high and low glucose alarms* for those who need them

Optional, real-time glucose alarms* do not require scanning

Alarms* trigger when glucose readings cross customized levels

Patients scan the sensor to see their glucose reading

Innovative Sensor

FreeStyle Libre 2 sensor is designed to improve patient experience

SMALL, DISCREET, AND EASY FOR PATIENTS2

In a study by Abbott Diabetes Care, 91.1% of patients surveyed (n=123) agreed that the sensor was small and easy to wear.1

Patients can scan to get their glucose level as often as they want||

Measures glucose every minute and stores readings every 15 minutes—showing 8 hours of glucose history.

VERY THIN FILAMENT

Filament is <0.4 mm thick and inserted 5 mm beneath the skin to measure interstitial fluid.

WORN UP TO 14 DAYS ON BACK OF UPPER ARM

Scan to activate, then wait 1 hour for first glucose reading||

FACTORY CALIBRATED

Accuracy not dependent on patient fingerstick calibration.

WATER RESISTANT

Patients can exercise, shower and swim in a depth of up to 1 meter (3 feet) for 30 minutes.

FreeStyle Libre 2 system is easy for you and your patients†2

  • Stores up to 90 days of glucose data, so you and your patients can see patterns and historic trends
  • 80% of FreeStyle Libre 2 users report that it enables them to adjust insulin doses more frequently†3
  • 92% of FreeStyle Libre 2 users feel it makes managing meal-time glucose easier†3

Real-time Glucose Readings and Easy-to-interpret Reports

Helps patients track key factors impacting glucose throughout the day such as food, insulin, and exercise

select the reader feature you’d like to view

Visual alerts and trend arrows

  • Warn patients when their glucose is going high or low
FreeStyle Libre reader visual alerts and trend arrows

Daily Patterns Graph

  • Helps patients assess glucose variability and identify periods when they are out of range
FreeStyle Libre reader daily patterns graph

Time in Target Chart

  • Shows patients how often they are in target range
FreeStyle Libre reader time in target chart

Average Glucose Graph

  • Indicates patients’ average glucose levels at various times of day
FreeStyle Libre reader average glucose graph

Low Glucose Events Graph

  • Reports the frequency of hypoglycemia events by time of day
FreeStyle Libre reader low glucose events graph
NOTE: Reader reports are available for 7, 14, 30, and 90 days.

How patients get started with FreeStyle Libre 2 system

FreeStyle Libre 2 system makes it easy2 for patients to apply, scan, and assess their data

Easy for patients to start

Easy to start

  • Apply sensor to back of upper arm
  • Scan sensor to activate, then wait 1 hour for first glucose reading||
Easy for patients to scan

Easy to scan

  • Painless2 glucose readings anytime||
  • Wear sensor for up to 14 days
Easy-to-access reports

Easy to access reports

  • Get optional glucose alarms* and real-time readings for insulin dosing on the reader
  • Healthcare professional reports created by downloading reader data#

FreeStyle Libre 2 is more affordable** than other CGM systems

Patients can fill their prescriptions at participating retail phamracies

Have a sales representative tell you more

A rep can keep you informed about new and existing Abbott products

Looking for a professional CGM system for your practice?

FreeStyle Libre Pro system offers many features that will make you rethink professional CGM.

*Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device.

Data from this study was collected with the outside US version of FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional, real-time glucose alarms. Therefore, the study data is applicable to both products.

Data based on the number of patients assigned to each manufacturer based on last filled prescription in US Retail Pharmacy and DME.

§Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.

||Glucose readings are not available during 1-hour warm-up, when sensor is too hot or too cold, when you see an error or "LO" or "HI" message, or no current glucose reading.

Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.

#LibreView is developed, distributed, and supported by Newyu, Inc. The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

**Based on a comparison of list prices of FreeStyle Libre 2 system versus competitors’ CGM systems. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.

References: 1. FreeStyle Libre 2 User's Manual. 2. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55-73. 3. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care. 2019;7(1):e000809. doi:10.1136/bmjdrc-2019-000809.

ADC-21507 v1.0 08/20